EB-1B Outstanding Researcher Green Card for Seattle Scientists
The EB-1B outstanding researcher category requires a permanent job offer from a qualifying U.S. research institution — making it employer-dependent, unlike EB-1A. In Seattle, the dominant EB-1B sponsors are the University of Washington and Fred Hutchinson Cancer Center, together with the Allen Institutes, Seattle Children's Research Institute, and qualifying research departments at Boeing. The standard — outstanding in the specific academic field — is lower than EB-1A's extraordinary ability and accessible to strong early- and mid-career researchers.
Outstanding researchers across Seattle's institutions.
EB-1B in Seattle originates primarily from the University of Washington and Fred Hutchinson Cancer Center. UW's International Scholar Services office is experienced with outstanding-researcher petitions across a broad range of fields — from genomics and molecular biology to computer science, public health, and atmospheric science. When UW offers a ladder-rank faculty appointment (Assistant Professor and above) or a comparable permanent research appointment, UW can sponsor EB-1B, with the university's appointment and promotion review providing institutional documentation of outstanding ability. Fred Hutch has its own immigration support and sponsors EB-1B for permanent Faculty Scientist and Associate Professor-equivalent positions in cancer biology, immunotherapy, and hematopoietic stem cell research.
The Allen Institutes — qualifying as large nonprofit research institutions — add an important EB-1B avenue for neuroscience and AI researchers receiving permanent appointments. Seattle Children's Research Institute sponsors EB-1B for permanent pediatric research faculty. Boeing qualifies as a private-employer sponsor for senior engineers in qualifying R&D departments. Across all sponsors, the researcher's publication record, citation profile, peer review service, awards, and recognition in the field form the evidence base.
University of Washington
Sponsors EB-1B for ladder-rank faculty across UW Medicine, the Paul G. Allen School of CS, Genome Sciences, Atmospheric Sciences, Public Health, and Biochemistry; UW's International Scholar Services office is experienced with EB-1B filings; UW's top-10 global rankings across multiple fields support the distinguished-organization argument in every department.
Fred Hutchinson Cancer Center
Sponsors EB-1B for permanent Faculty Scientist and Associate Member appointments in oncology, immunotherapy, hematopoietic stem cell research, and cancer epidemiology; Fred Hutch's Nobel Prize-connected heritage and NCI designation support the distinguished-organization requirement; publications in NEJM, JCI, Cancer Cell, and Nature Medicine form the scholarly-articles base.
Allen Institute for Brain Science
Sponsors EB-1B for permanent Staff Scientist appointments; the Allen Brain Atlas's international recognition establishes the Institute as a distinguished research organization; researchers qualify through publications in Nature Neuroscience, Neuron, and Cell; the Allan Institute's large, NIH-funded research programs provide grant-funding documentation of the researcher's funded role.
Allen Institute for AI (AI2)
Qualifies as a nonprofit research institution for EB-1B under the three-researcher / documented-accomplishments route; sponsors permanent Staff Research Scientist appointments; publications at NeurIPS, ICML, ACL, and EMNLP form the scholarly-articles base; AI2's open-source tools (Semantic Scholar, OLMo) and documented research output establish institutional accomplishments.
Seattle Children's Research Institute
Sponsors EB-1B for permanent pediatric research faculty in oncology, immunology, genetics, and neurodevelopment; affiliated with UW and one of the largest pediatric research institutes in the Pacific Northwest; publications in Pediatrics, JAMA Pediatrics, and Blood provide the scholarly-articles anchor; NCI and NIAID funding supports the funded-program documentation.
Boeing (private-employer route)
Boeing qualifies for EB-1B as a private employer with a qualifying R&D department in Renton and Everett; the aeronautical engineering and materials science departments employ more than three full-time researchers and have documented accomplishments through AIAA publications, patents, and FAA-certified aircraft programs; senior technical specialists in qualifying research roles may receive EB-1B sponsorship, though many prefer employer-independent EB-1A.
Eligibility criteria
EB-1B criteria for Seattle researchers.
EB-1B requires at least two of six criteria, plus a permanent job offer and at least three years of experience in the field. The six criteria are distinct from — and generally lower-threshold than — EB-1A criteria. Seattle researchers typically satisfy three or four.
CRITERION 01
Prizes or awards for excellence
NSF CAREER, NIH Career Development Award, NCI Outstanding Investigator Award, Parker Institute for Cancer Immunotherapy funding award, Burroughs Wellcome Fund award, AIAA recognition for aerospace, best paper awards at NeurIPS/ICML/ICLR for CS researchers.
CRITERION 02
Membership in associations requiring outstanding achievement
ACM Fellow, IEEE Fellow, AAAI Fellow; National Academy of Sciences or Medicine for senior figures; AAAS Fellow; election to editorial boards of major journals requiring demonstrated expertise — not simply application.
CRITERION 03
Published material in major media
Coverage in STAT News, Wired, MIT Technology Review, The Scientist, Nature News, or Science News about the researcher's work; profiles in Seattle Times science section; institutional press releases picked up by national trade media.
CRITERION 04
Judging the work of others
NIH or NSF review panels; NCI or NHGRI study sections; NeurIPS, ICML, ACL, or CVPR program committee service; editorial board and manuscript peer review for major journals; AIAA technical committee for aerospace researchers.
CRITERION 05
Original scientific or scholarly contributions
Protein design methods enabling new biomedical applications; genomics pipelines adopted across the field; Allen Brain Atlas data resources cited globally; cancer immunotherapy protocols used at multiple cancer centers; AI frameworks widely adopted by the research community.
CRITERION 06
Authorship of scholarly articles
Publications in Science, Nature, Cell, NEJM, Nature Medicine, Nature Genetics, Nature Neuroscience, or top CS venues (NeurIPS, ICML, ICLR, ACL, SOSP) as first or senior author; citation counts consistent with outstanding standing in the specific subspecialty.
Seattle EB-1B profiles
What qualifying records look like here.
Representative profiles from Seattle EB-1B petitions. Identifying details have been generalized.
Assistant Professor
UW Department of Genome Sciences
Single-cell multi-omics and spatial transcriptomics of the developing nervous system
19 publications; senior-author papers in Nature Methods, Nature Neuroscience, and Cell
NIH R01 (PI) and Chan Zuckerberg Initiative award
NHGRI study section ad hoc reviewer; editorial board, Genome Research
Invited speaker at ASHG Annual Meeting and EMBL symposia
UW sponsored EB-1B through the tenure-track Assistant Professor appointment. The appointment and promotion committee's review served as institutional documentation; editorial board satisfied judging; the publication and citation record satisfied scholarly articles; original contributions were anchored to spatial transcriptomics methods adopted by labs internationally.
Faculty Scientist
Fred Hutchinson Cancer Center — Vaccine and Infectious Disease Division
B cell memory and durable antibody responses following cancer vaccination
16 publications; senior-author papers in JCI, Cell Reports, and Journal of Immunology
NIH R01 (PI); Parker Institute for Cancer Immunotherapy award
AAI Abstract Review Committee; peer reviewer for Journal of Immunology
Fred Hutch sponsored EB-1B through the permanent Faculty Scientist appointment. The Parker Institute award satisfied prizes; AAI review committee satisfied judging; the publication record satisfied scholarly articles. Expert letters from independent B cell biologists at other cancer centers described the researcher's standing in the cancer vaccine immunology subspecialty.
Staff Research Scientist
Allen Institute for AI (AI2) — Seattle
Reasoning capabilities and factual grounding in large language models
14 publications at NeurIPS, ICLR, ACL, and EMNLP; 3 papers cited 400+
ICLR and ACL program committee; invited talk at NAACL
Creator of an open-source reasoning benchmark (GitHub: 6K+ stars)
AI2 sponsored EB-1B under the nonprofit research institution route, documenting its research staff size and output (Semantic Scholar, OLMo, published research across ML/NLP). Scholarly articles (top NLP/ML venues), judging (program committee), and original contributions (reasoning benchmark adopted across the AI research community) were the lead criteria.
Choosing between pathways
EB-1B vs. EB-1A for Seattle researchers — which path first?
EB-1B and EB-1A are complementary green card paths most powerful when filed simultaneously. EB-1B is employer-sponsored — requires a permanent job offer. EB-1A is self-petitioned — requires no employer. Both are EB-1 preference category petitions. For Seattle researchers at UW or Fred Hutch, the common pattern is for the institution to sponsor EB-1B while the researcher simultaneously self-petitions EB-1A — the EB-1A follows the researcher to another institution, into Seattle's biotech sector, or to a tech company research role, regardless of what the EB-1B does.
For Indian and Chinese nationals, this parallel strategy is especially important: filing both I-140s as early as the record allows locks in the earliest possible priority date in the EB-1 category, where the backlog is shorter than EB-2 or EB-3. If EB-1B is denied, EB-1A proceeds independently. For researchers early enough in their careers that EB-1A is not yet achievable, EB-1B is the right first step — with NIW filed simultaneously to establish an early EB-2 priority date. Consult the Visa Bulletin for current cutoff dates.
FAQ
Seattle EB-1B questions.
UW's International Scholar Services office sponsors EB-1B for ladder-rank faculty (Assistant Professor and above) across UW Medicine, the Allen School of CS, Genome Sciences, and other schools. The hiring department initiates the sponsorship request and documents the permanent appointment, and UW's ISS office coordinates the I-140 filing with outside counsel. The researcher (through counsel) assembles the evidence package: publications, citation analysis, expert letters from independent authorities in the subspecialty, peer review records, and awards. UW's global top-10 rankings across computer science, molecular biology, and public health support the distinguished-organization argument across multiple fields.
Yes. Fred Hutchinson Cancer Center, as a nonprofit research institution with a substantial permanent research faculty, qualifies as an EB-1B sponsor for permanent appointments (Faculty Scientist, Associate Professor, and comparable permanent research positions). Fred Hutch's HR and immigration team coordinates EB-1B filings with outside counsel. The evidence package draws on the researcher's publications in major oncology and immunology journals, NCI funding history, study section service, and recognition in the field. Fred Hutch's two Nobel Prize-connected research heritage provides a strong distinguished-organization anchor.
Yes, under the nonprofit research institution route for EB-1B. Both Allen Institutes are large nonprofit research institutions that employ more than three full-time researchers and have documented accomplishments in their fields — the Allen Brain Atlas and AI2's published research and open-source tools are the documentation. When the Allen Institutes offer permanent research appointments, they can sponsor EB-1B for outstanding researchers. The evidence package for Allen Brain Science EB-1B typically includes publications in Nature Neuroscience and Cell; peer review service; and independent expert letters. For AI2, conference publications at NeurIPS, ACL, and ICLR form the scholarly-articles basis.
EB-1B requires recognition as outstanding in the specific academic field — lower than EB-1A's extraordinary ability (the very top of the field globally) but higher than NIW's well-positioned standard. For Seattle researchers, the typical EB-1B profile: a strong publication record in top journals or peer-reviewed conference proceedings with growing citations; service on NIH or NSF review panels or editorial boards; a research award from a scientific or professional society; and recognition by peers in expert letters that specifically describe the researcher's standing relative to others in the subspecialty. EB-1B requires at least three years of experience — doctoral and postdoctoral research generally counts.
Where the employer is willing to sponsor and the record supports it, filing both is the strongest strategy. EB-1B (employer-sponsored) and EB-1A (self-petitioned) are both EB-1 preference categories and both avoid PERM. Filing both produces two independent I-140s: if one is denied or the researcher changes institutions, the other survives. For Seattle researchers at UW or Fred Hutch, the common pattern is for the institution to sponsor EB-1B while the researcher simultaneously self-petitions EB-1A — the EB-1A follows the researcher to another institution, into Seattle's biotech sector, or to a tech company research role. For Indian and Chinese nationals facing the EB-1 backlog, filing both as early as the record allows locks in the earliest possible priority date.
